All feces and pseudofeces produced were captured using a micropipette in the moment of expelling and preserved in 1% Lugol solution
. To assess it, the PPRs samples were disintegrated in an ultrasound Bandelin Sonorex RK 100H for 10 minutes to separate cells from the mucus and counted in a Sedgewick-Rafter chamber ([mm.sup.3].[L.sup.-1]).
Pseudofeces and feces were captured in the moment of expelling using a micropipette and preserved in 1% Lugol solution
. Pseudofeces were disintegrated for 10 minutes using ultrasound Bandelin Sonorex RK100H to separate cells from the mucus and then enable the counting of food particles.
(6) That amount, 0.075 mg of bioavailable iodide, represents less than 1% of the amount of iodide used in Marine's study (2,3) (i.e., 9 mg) and also less than 1% of the recommended daily intake of iodine from Lugol solution
. Implementation of iodization of salt was associated with an increased incidence of autoimmune thyroiditis.
Iodization of salt gave a false sense of iodine sufficiency and resulted in the public relying on iodized salt for supplementation instead of the previously used forms of iodine and iodide such as the Lugol solution
in the recommended daily amount of 0.1-0.3 ml containing 12.5-37.5 mg elemental iodine.
As far back as 100 years ago, US physicians used Lugol solution
extensively in their practice for many medical conditions.
(2) Just think how healthy our population would be if the average consumption of iodine/iodide by supplementation was in the range consumed by mainland Japanese, i.e., in the range recommended by US physicians in the form of Lugol solution
before World War II.
The literature search also revealed that US physicians over the past century used Lugol solution
extensively in their practice for both hypo- and hyperthyroidism.
Iodoral[R] is the tablet form of Lugol solution
containing 12.5 mg elemental iodine per tablet.
Using ion-selective electrode measurement, following chromatography on anion-exchange resins, (27) serum inorganic iodide levels were measured by the author serially for 24 hours in five normal subjects and one obese man, following a single ingestion of 37.5 mg of iodine/iodide from a tablet form of Lugol solution
(three tablets of Iodoral[R]).
However, Wartofsky, et al (29) in 1970, evaluated the effect of Lugol solution
, administered at five drops (30 mg iodine/iodide) three times a day in five thyrotoxic patients.
Plummer was the first to use Lugol solution
pre- and post-operatively in his management of Grave's disease.
This time-tested Lugol solution
has been available since 1829, when it was introduced by French physician Jean Lugol.